Sudden Sensori Neural Hearing Loss clinical trials

Explore recruiting sudden sensori neural hearing loss clinical trials.

Also recruiting in Europe

Sudden Sensori Neural Hearing Loss trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Intracochlear Triamcinolone acetonide in sudden sensorineural hearing loss patients - a prospective observer blinded randomized study

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Sudden Sensori Neural Hearing Loss trials by city

Sudden Sensori Neural Hearing Loss in Toronto Sudden Sensori Neural Hearing Loss in Vancouver Sudden Sensori Neural Hearing Loss in Montreal Sudden Sensori Neural Hearing Loss in Calgary Sudden Sensori Neural Hearing Loss in Edmonton Sudden Sensori Neural Hearing Loss in Ottawa Sudden Sensori Neural Hearing Loss in Winnipeg Sudden Sensori Neural Hearing Loss in Quebec City Sudden Sensori Neural Hearing Loss in Hamilton Sudden Sensori Neural Hearing Loss in Kitchener Sudden Sensori Neural Hearing Loss in London Sudden Sensori Neural Hearing Loss in Halifax Sudden Sensori Neural Hearing Loss in New York Sudden Sensori Neural Hearing Loss in Los Angeles Sudden Sensori Neural Hearing Loss in Chicago Sudden Sensori Neural Hearing Loss in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease